6078:HKEXHygeia Healthcare Holdings Co., Ltd. Analysis
Data as of 2026-03-17 - not real-time
¥1,390.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Value HR Co.,Ltd. shows strong top‑line momentum with double‑digit revenue growth and solid cash generation, yet its price‑earnings multiple is markedly higher than the healthcare information services average, indicating a stretched valuation. The discounted cash‑flow estimate sits well below the current market price, and the dividend payout exceeds earnings, raising questions about sustainability.
On the technical side, the short‑term moving average lies beneath the medium‑term average, confirming a bearish price trend, while the relative strength index remains in a neutral band and the MACD histogram has turned positive, hinting at a possible short‑term bounce. Low beta suggests limited market‑wide volatility, but the recent 30‑day price swings are elevated and the stock trades near a key support level, making downside risk tangible despite stable trading volumes.
On the technical side, the short‑term moving average lies beneath the medium‑term average, confirming a bearish price trend, while the relative strength index remains in a neutral band and the MACD histogram has turned positive, hinting at a possible short‑term bounce. Low beta suggests limited market‑wide volatility, but the recent 30‑day price swings are elevated and the stock trades near a key support level, making downside risk tangible despite stable trading volumes.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish moving‑average crossover
- Neutral RSI indicating no overbought pressure
- Proximity to a defined support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation gap between market price and DCF fair value
- Robust revenue growth but high PE relative to peers
- Elevated dividend payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue expansion and cash flow generation
- Defensive sector with low beta
- Potential upside if valuation compresses toward fundamentals
Key Metrics & Analysis
Financial Health
Revenue Growth23.60%
Profit Margin6.25%
P/E Ratio60.2
ROE9.25%
ROA3.06%
Debt/Equity73.70
P/B Ratio5.4
Op. Cash Flow¥1.6B
Free Cash Flow¥681.9M
Industry P/E26.4
Technical Analysis
TrendBearish
RSI43.0
Support¥1,362.00
Resistance¥1,452.00
MA 20¥1,407.70
MA 50¥1,422.88
MA 200¥1,590.98
MACDBullish
VolumeStable
Fear & Greed Index79.71
Valuation
Fair Value¥896.31
GradeOvervalued
TypeGrowth
Dividend Yield1.92%
Risk Assessment
Beta0.12
Volatility17.10%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.